Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00731042Phase 4Completed
Phase 4, randomised trial of chlorhexidine + ethyl alcohol in Infection prevention (IPC), sponsored by Solventum. Primary endpoint: Visual Skin Score at 14 days. Started Mar 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00731042.